Folinic Acid Calcium Salt, Pentahydrate
Application Notes
Folinic Acid Calcium Salt, Pentahydrate offsets the effects of folic acid antagonists that act by binding dihydrofolate reductase and blocking the conversion of folic acid to tetrahydrofolate. In medicine, calcium folinate is used after treatment with methotrexate to reduce the toxicity of the methotrexate. Calcium folinate is also used to enhance the cytotoxic effect of 5-fluorouracil in the treatment of cancer.
Usage Statement
Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
SKU | 02191504-CF |
Alternate Names | 5-Formyl-5,6,7,8-tetrahydrofolic acid calcium salt; 5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid calcium salt; 5-HCO-H4PteGlu; Calcium folinate; Citrovorum factor calcium salt; Leucovorin calcium salt; N5-Formyl-5,6,7,8- tetrahydropteroyl-L-glutamic acid calcium salt; CF; N-[p-[[(2-amino-5-formyl-5,6,7,8-tetrahydro-4- hydroxy-6- pteridinyl) methyl] amino] benzoyl] glutamic acid calcium salt; N-[4-[[(2-Amino-5-formyl-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl) methyl] amino] benzoyl]-Lglutamic acid calcium salt |
Application Notes | Folinic Acid Calcium Salt, Pentahydrate offsets the effects of folic acid antagonists that act by binding dihydrofolate reductase and blocking the conversion of folic acid to tetrahydrofolate. In medicine, calcium folinate is used after treatment with methotrexate to reduce the toxicity of the methotrexate. Calcium folinate is also used to enhance the cytotoxic effect of 5-fluorouracil in the treatment of cancer. |
Base Catalog Number | 191504 |
Beilstein Registry Number | 5723924 |
Biochemical Physiological Actions | Intermediate product of the metabolism of folic acid; the active form into which that acid is converted in the body, ascorbic acid being a necessary factor in the conversion process. |
CAS # | 6035-45-6 |
EC Number | 216-082-8 |
Format | Powder |
Hazard Statements | H315-H317-H319-H334-H335 |
Molecular Formula | C20H21N7O7Ca |
Molecular Weight | 601.58 g/mol |
RTECS Number | MA0600500 |
Safety Symbol | GHS07, GHS08 |
Solubility | DMSO « 1 (mg/mL) |
Usage Statement | Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department. |